Lijiang F. Chen
Wenzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Anti-interferon-γ autoantibody-associated adult-onset immunodeficiency with occult immunological abnormalities and sequential intracellular infections: a case report.
Journal: Frontiers in immunology
Published: March 27, 2026
Evaluation of the performance of a novel chemiluminescence immunoassay for cryptococcal antigen detection.
Journal: Microbiology spectrum
Published: March 10, 2026
Combination of 7-hydroxyflavone and colistin: antibacterial activity and mechanism against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
Journal: BMC microbiology
Published: December 01, 2025
Retraction notice to "Verapamil increases susceptibility of colistin-resistant Acinetobacter baumannii to colistin" [International Journal of Antimicrobial Agents 64 (2024), 107233].
Journal: International journal of antimicrobial agents
Published: January 31, 2025
Microbial mechanical insights into the cadmium accumulation of rice (Oryza sativa L.) grains in Cd-contaminated seleniferous paddy soils: A data-driven observational research.
Journal: Journal of hazardous materials
Published: January 22, 2025
Host immunity involvement in the outcome of phage therapy against hypervirulent Klebsiella pneumoniae infections.
Journal: Antimicrobial agents and chemotherapy
Published: May 14, 2024
Genome analysis of tigecycline-resistant Acinetobacter baumannii reveals nosocomial lineage shifts and novel resistance mechanisms.
Journal: The Journal of antimicrobial chemotherapy
Published: May 09, 2024
Immunomodulator AS101 restores colistin susceptibility of clinical colistin-resistant Escherichia coli and Klebsiella pneumoniae in vitro and in vivo.
Journal: International journal of antimicrobial agents
Published: May 06, 2024
Impact of LuxS on virulence and pathogenicity in Klebsiella pneumoniae exhibiting varied mucoid phenotypes.
Journal: Infection and immunity
Published: February 15, 2024
An effective antimicrobial strategy of colistin combined with the Chinese herbal medicine shikonin against colistin-resistant Escherichia coli.
Journal: Microbiology spectrum
Published: October 06, 2023
PAM-1: an antimicrobial peptide with promise against ceftazidime-avibactam resistant Escherichia coli infection.
Journal: Frontiers in microbiology
Published: September 10, 2023
Last Updated: 09/26/2026